US PRE-MARKET MOVERS: REGN, F, D, RAMP, UNH, BIO, NOW

ES -0.2% NQ -0.1% RTY -0.1% REGN -11.5%: Melanoma combo fails Phase 3 primary endpoint.. F +5.5%: Plans to launch seven new vehicle models in Europe by 2029. D +15.0%, NEE -1.7%: NEE to acquire D in all-stock deal. RAMP +27.8%: Publicis agreed to buy RAMP in an all-cash $2.2B deal. UNH -3.8%: BRK.B exits UNH position. BIO +7.5%: Elliott builds BIO stake. NOW +5.1%: BofA reinstated coverage with a 'Buy' rating and $130 PT.